Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

A seasoned small business and technology writer and educator with more than 20 years of experience, Shweta excels in demystifying complex tech tools and concepts for small businesses. Her work has ...

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.

Progress in preventing infections was being made in the country with Europe's second-highest number of HIV cases. Then came ...

In a session at AIDS 2024, the International AIDS Conference, global leaders and community advocates gathered to discuss why ...

The hotly anticipated results are in from a landmark pair of major clinical trials of a long-acting, injectable ...

What is being announced at the Apple event? Stay tuned and find out. Credit: Mashable composite; Shutterstock / SkyArtist01, Champiofoto / Apple Wondering what you should expect from Apple's big ...

The quantitative analysis found that there were no differences between the PPD measures in patients both with and without HIV (mean difference, –0.16; 95% CI, –0.47 to 0.15). Studies found a ...

What does that mean for countries and for you ... This includes people living with HIV whose viral load is not well controlled. Mpox is a virus and as with all viral infections it's the immune system ...

Of the 95 per cent of them receiving treatment, 98 per cent had an undetectable viral load, meaning they could not transmit the disease. In 2019, Australian HIV diagnoses had hit an 18-year low ...

It happens to all of us: a song gets stuck in your head, and no matter how hard you think about it, you just can’t remember the name of the song. Fortunately, there are plenty of ways to help you ...

A new study has uncovered empirical evidence that shows what researchers have long suspected about HIV risk—that having multiple risk factors is much worse than having only one. Pablo Kokay ...